Disease · MONDO_0005313
Trials13
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 2 more are not shown, since the checks do not confirm them.
1 to 13 of 13
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01827358 | Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants | Phase 2 | 155 | 2017-07-07 | Staphylococcal Infection | MUPIROCIN | Its record names the disease | ClinicalTrials.gov |
| NCT01222585 | Metronidazole Pharmacokinetics (PK) in Premature Infants | Phase 1 | 24 | 2013-12-18 | Serious Systemic Infections, Necrotizing Enterocolitis | METRONIDAZOLE | Its record names the disease | ClinicalTrials.gov |
| NCT01156480 | Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants | Not applicable | 2 | 2014-03-24 | Necrotizing Enterocolitis | HYDROCORTISONE | Its record names the disease | ClinicalTrials.gov |
| NCT04347720 | Canadian National PDA Treatment Study | 1,663 | Patent Ductus Arteriosus, Extreme Prematurity | ACETAMINOPHEN, IBUPROFEN, INDOMETHACIN | Its record names the disease | ClinicalTrials.gov | ||
| NCT02884219 | Early Treatment Versus Expectative Management of PDA in Preterm Infants | Not applicable | 273 | Patent Ductus Arteriosus | IBUPROFEN, INDOMETHACIN | Its record names the disease | ClinicalTrials.gov | |
| NCT03860428 | Early Treatment Versus Expectant Management of PDA in Preterm Infants | Not applicable | 208 | Patent Ductus Arteriosus | ACETAMINOPHEN, IBUPROFEN | Its record names the disease | ClinicalTrials.gov | |
| NCT06048614 | Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis. | Not applicable | 95 | Meconium Obstruction of Prematurity | GLYCERIN, SODIUM CHLORIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT02819414 | Paracetamol Treatment of the Borderline Significant PDA | Phase 2 | 80 | Patent Ductus Arteriosus | ACETAMINOPHEN | Its record names the disease | ClinicalTrials.gov | |
| NCT06422000 | Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis | Phase 3 | 75 | Necrotizing Enterocolitis | PENTOXIFYLLINE | Its record names the disease | ClinicalTrials.gov | |
| NCT04696003 | Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion | Phase 3 | 68 | Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Intracranial Hemorrhages | AMOXICILLIN, AZITHROMYCIN, CLARITHROMYCIN | Its record names the disease | ClinicalTrials.gov | |
| NCT00271336 | Pentoxifylline in the Treatment of NEC in Premature Neonates | Phase 2 | 50 | Necrotizing Enterocolitis | PENTOXIFYLLINE | Its record names the disease | ClinicalTrials.gov | |
| NCT02050971 | Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates | Phase 1 | 40 | Anemia, Neonatal, Intracranial Hemorrhages, Necrotizing Enterocolitis, Respiratory Distress Syndrome, Newborn, Retinopathy of Prematurity, Bronchopulmonary Dysplasia | AUTOLOGOUS CORD BLOOD | Its record names the disease | ClinicalTrials.gov | |
| NCT06547424 | Phase I Clinical Study of Chondroitin Sulfate for Treatment of NEC | Phase 1 | 0 | Necrotizing Enterocolitis, Intestinal Ischemia | CHONDROITIN SULFATE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005313/trials